Health Care & Life Sciences » Biotechnology | Shandong Sinobioway Biomedicine Co. Ltd.

Shandong Sinobioway Biomedicine Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
468
454
874
769
1,816
1,676
Total Accounts Receivable
76
75
476
674
821
679
Inventories
26
33
62
64
60
42
Other Current Assets
7
12
8
8
4
126
Total Current Assets
577
573
1,420
1,515
2,702
2,523
Net Property, Plant & Equipment
162
163
480
486
506
1,055
Total Investments and Advances
-
-
213
353
453
435
Intangible Assets
35
34
292
288
298
135
Other Assets
-
-
4
12
9
126
Total Assets
774
769
2,416
2,688
3,998
4,298
ST Debt & Current Portion LT Debt
-
-
-
113
101
Accounts Payable
20
10
28
34
26
Income Tax Payable
5
3
22
27
34
Other Current Liabilities
8
5
73
67
96
Total Current Liabilities
33
18
235
128
257
Long-Term Debt
-
-
1
1
791
Deferred Taxes
-
-
10
20
15
Total Liabilities
33
18
253
143
1,064
Common Equity (Total)
738
749
2,085
2,469
2,858
Total Shareholders' Equity
738
749
2,085
2,469
2,858
Total Equity
738
749
2,144
2,527
2,920
Liabilities & Shareholders' Equity
774
769
2,416
2,688
3,998
Accumulated Minority Interest
-
-
59
58
62
Non-Equity Reserves
2
2
19
17
15

About Shandong Sinobioway Biomedicine Co.

View Profile
Address
Peking University Biological City
Beijing Shandong 100085
China
Employees -
Website http://www.sdsinobioway.com
Updated 07/08/2019
Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. Its products include pharmaceutical intermediates and pesticide intermediates. The company was founded on January 18, 2000 and is headquartered in Beijing, China.